Precipio was founded
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
-
-
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
-
HHS announced advanced development contract for new way to make flu vaccine
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
-
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
-
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
-
Yale New Haven Hospital breaks ground on $838 million, 505,000 square foot Neurosciences Center
On Aug. 31, 2022, Yale New Haven Hospital (YNHH) broke ground on the $838 million, 505,000 square foot…
-
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
-
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
-
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
-
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
-
Bristol-Myers’ Wallingford facility named the Richard L Gelb Center for Pharmaceutical R&D after former Bristol-Myers chair and CEO
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
-
CDC Launched National surveillance for Lyme disease
In 1992, the U.S. Centers for Disease Control and Prevention (CDC) launched a national surveillance for tick-borne Lyme…
-
Connecticut United for Research Excellence (CURE) was founded
In 1990, Connecticut United for Research Excellence Inc. (CURE) was founded. CURE was a statewide coalition of educational…
-
Connecticut Innovations was founded
In 1989, Connecticut Innovations (CI), created by the Connecticut Legislature, provides strategic capital and operational support to advanced…
-
Yale Cancer Center oncologists performed the first bone marrow transplant in Connecticut
In 1988, oncologists from Yale Cancer Center performed the first bone marrow transplant in Connecticut at the Yale-New…
-
Researchers from the University of Pennsylvania and the University of Washington injected purified DNA into a single-cell mouse embryo
On Jul. 9, 1981, Frank Ruddle from Yale University, Frank Costantini and Elizabeth Lacy from Oxford, and Ralph…
-
Joan Steitz discovered snRNPs
In 1979, Joan Steitz discovered snRNPs, RNA-protein complexes in the cell’s nucleus that perform a crucial step in…
-
Lyme Disease was identified and named
In 1981, researcher William Burgdorfer, Ph.D., at the National Institute for Allergy and Infectious Diseases (NIAID) Rocky Mountain…
-
Yale Cancer Center received NCI-designated comprehensive cancer center status
In 1974, Yale Cancer Center received a National Cancer Institute (NCI) designated comprehensive cancer center status, the only…
-
Yale established the first university-based department of clinical pharmacology and chemotherapy in the US
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…
-
Yale New Haven Hospital (then Grace-New Haven) installed the first linear accelerator in Connecticut for cancer treatment
In 1963, Yale New Haven Hospital (then Grace-New Haven) installed the first linear accelerator in Connecticut for cancer…
-
The first antiviral drug was developed at Yale
In 1959, William Prusoff of Yale University discovered idoxuridine, the first effective antiviral that fights herpes by interfering…
-
Yale established first pharmacology department in the U.S. to focus on cancer chemotherapy and drug development
In 1953, Yale established the first pharmacology department in the U.S. to focus on cancer chemotherapy and cancer…
-
The first artifical heart pump developed
In 1949, the first artificial heart pump was developed at Yale by William H. Sewell and William W….
-
First intravenous chemotherapy treatment of a cancer patient was performed at Yale University,
In 1942, the first intravenous chemotherapy treatment of a cancer patient was performed at Yale.
-
Chemotherapy began when the first use of a cancer drug was administered to a patient using nitrogen mustard
In 1942, Yale cancer research began when the first use of a cancer drug was administered to a…
-
Storrs Agricultural School became the University of Connecticut
On Jul. 1, 1939, Storrs Agricultural School became the University of Connecticut. Many in the University community believed…
-
Radioactive isotope first used to treat human disease
On Dec. 24, 1936, John Lawrence, known as the “father of nuclear medicine,” treated a a 28-year-old patient…
-
George Hoyt Whipple was awarded Nobel Prize in Medicine
In 1934, George Hoyt Whipple, a graduate of Yale University (A.B. 1900), was awarded the 1934 Nobel Prize…
-
Donald Jones invented the double-cross that moves hybrid corn from the lab into farmers’ fields
In 1918, geneticist Donald Jones invents the double-cross (the crossing of two single crosses) that moves hybrid corn…
